相关实验视频
Updated: Sep 20, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
872
在晚期慢性病中与代谢功能障碍相关的脂肪肝疾病:对患者生存的影响
Cesar Garcia-Cantón1,2, Yaiza Rivero1, Elvira Bosch1
1Nephrology Department, Hospital Universitario Insular Gran Canaria, Las Palmas de Gran Canaria, Spain.
Nephron
|May 25, 2025
概括
与代谢功能障碍相关的脂肪肝疾病 (MAFLD) 在晚期慢性病 (CKD) 中很常见,特别是在糖尿病患者中. MAFLD独立地预测了ACKD糖尿病患者的生存率降低.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 肝病学 肝病学是一种肝病学.
- 代谢疾病 代谢疾病
背景情况:
- 与代谢功能障碍相关的脂肪肝疾病 (MAFLD) 与心血管事件和死亡率有关.
- MAFLD和慢性病 (CKD) 具有共同的病理生理学联系.
- MAFLD在肥胖,代谢综合征和2型糖尿病中普遍存在.
研究的目的:
- 在晚期慢性病 (ACKD) 中确定MAFLD的患病率.
- 在ACKD患者中确定与MAFLD相关的因素.
- 评估MAFLD对ACKD患者生存率的影响.
主要方法:
- 对367名患有4-5期CKD的患者进行了回顾性纵向队列研究 (2011-2015年).
- 使用脂肪肝指数 (FLI) 估计的MAFLD存在.
- 卡普兰-梅尔和考克斯回归分析评估了对生存的影响.
主要成果:
- 60.2%的人患有糖尿病,70.8%的人患有FLI≥60.
- 年龄和糖尿病与更高的FLI有关.
- 在糖尿病ACKD患者中,FLI独立预测了糖尿病ACKD患者的生存率下降 (HR 1.015,p=0.009).
结论:
- 在ACKD中,MAFLD非常普遍,特别是在糖尿病患者中.
- MAFLD是糖尿病ACKD患者生存率降低的独立风险因素.
- 在ACKD患者中需要MAFLD的预防和治疗策略.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
89
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
89
01:25Chronic Kidney Disease I: Introduction
84
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
84
01:24Chronic Kidney Disease II: Clinical Manifestations
110
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
110
01:18Chronic Kidney Disease IV: Nursing Management
62
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
62
01:11Renal Failure: Dose Adjustments
167
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
167
01:24Overview of Lipid Metabolism
2.6K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.6K